Fedratinib

Inrebic

Treatment Description

Fedratinib is a selective oral JAK2 inhibitor that is FDA approved for use in myelofibrosis. It is being studied for use in other indications as well.

Participating Centers

There are 4 centers running trials with this treatment. Enter a location below to find the closest center.